LH

LH

USD

Labcorp Holdings Inc. Common Stock

$252.720+5.880 (2.382%)

Precio en Tiempo Real

Healthcare
Diagnostics & Research
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$246.840

Máximo

$252.760

Mínimo

$244.520

Volumen

0.69M

Fundamentos de la Empresa

Capitalización de Mercado

21.0B

Industria

Diagnostics & Research

País

United States

Estadísticas de Negociación

Volumen Promedio

0.62M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $209.38Actual $252.720Máximo $293.72

Noticias Relacionadas

Analyst Upgrades

UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320

UBS analyst Kevin Caliendo maintains Labcorp Hldgs with a Buy and lowers the price target from $325 to $320.

Ver más
UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320
Reuters

Labcorp cuts growth outlook for research unit as biotech funding crunch persists

Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to weigh on its early-stage drug development clients.

Ver más
Labcorp cuts growth outlook for research unit as biotech funding crunch persists
Analyst Upgrades

Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support

Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong diagnostics and lab growth.

Ver más
Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support
PR Newswire

Labcorp Announces 2025 Third Quarter Results

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the third quarter ended...

Ver más
Labcorp Announces 2025 Third Quarter Results
PR Newswire

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the...

Ver más
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.